VEREDA THERAPEUTICS
DEAD

Serial Number

88758437

Owner

RETROPHIN, INC.

Attorney

Jared M. Barrett

Filing Date

Jan 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

VEREDA THERAPEUTICS Trademark

Serial Number: 88758437

VEREDA THERAPEUTICS is a trademark filed by RETROPHIN, INC. on January 14, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

RETROPHIN, INC. (70 trademarks)

Suite 200
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

January 14, 2020

Registration Date

Not Registered

Published for Opposition

May 12, 2020

Goods & Services

pharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention of monogenic diseases and disorders; pharmaceutical preparations for the treatment of monogenic diseases and disorders; pharmaceutical preparations for the prevention of metabolic diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; therapeutic preparations for the prevention of liver diseases and disorders; therapeutic preparations for the treatment of liver diseases and disorders; therapeutic preparations for the prevention of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the prevention of central nervous system diseases and disorders; therapeutic preparations for the treatment of central nervous system diseases and disorders; therapeutic preparations for the prevention of monogenic diseases and disorders; therapeutic preparations for the treatment of monogenic diseases and disorders; therapeutic preparations for the prevention of metabolic diseases and disorders; therapeutic preparations for the treatment of metabolic diseases and disorders

Providing health and medical information; providing a website featuring health and medical information

Research and development of pharmaceuticals for the treatment of rare diseases; medical research

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 8, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 8, 2021 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 7, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2020 NONP
ASSIGNED TO LIE
Apr 2, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 23, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 23, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 23, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 23, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 10, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 10, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 10, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 18, 2020 NWOS
NEW APPLICATION ENTERED
Jan 17, 2020 NWAP